Liver Transplant Size Matters: How Mismatches Impact Survival
"Discover the surprising link between donor and recipient liver size and its effect on transplant outcomes."
Liver transplantation is a life-saving procedure for individuals with end-stage liver disease. While living donor transplants allow for meticulous size matching between donor and recipient, deceased donor transplants often present challenges in achieving the same level of precision.
Traditionally, less emphasis has been placed on precise size matching in deceased donor liver transplantation compared to living donor procedures. However, emerging research suggests that size mismatches can significantly impact patient outcomes, highlighting the need for a closer look at current practices.
This article explores a recent study investigating the effects of liver size mismatch (SMM) in deceased donor liver transplantation, examining how these mismatches influence graft and patient survival rates. We'll break down the findings, discuss their implications, and consider what this means for improving transplant success.
U.S. Liver Waiting List in 2023
The OPTN/SRTR 2023 Annual Data Report says removals from the U.S. adult liver transplant waiting list for transplant outpaced new registrations in 2023. As a result, fewer adult candidates remained on the list at year’s end. HRSA notes that UNOS collects and manages data on the waiting list, organ donation and matching, and transplantation across the OPTN network.
The Impact of Size Mismatch on Transplant Success
A retrospective cohort study was conducted, analyzing data from 884 deceased donor liver transplant recipients between 2006 and 2015. The study classified patients based on Basal Surface Area index (BSAi) into three groups: small for size (SFS), normal for size (NFS), and large for size (LFS). Size mismatch (SMM) was defined as significant deviations from the normal range.
- Graft Survival: The mean 2-year graft survival was significantly lower in the SMM group compared to the NFS group (623 days vs. 660 days; p = .042).
- Patient Survival: Similarly, the mean 2-year patient survival was also significantly reduced in the SMM group (641 days vs. 672 days; p = .045).
Managing Small-for-Size Syndrome
A review published March 1, 2025, says management of established small-for-size syndrome centers on meticulous patient care. It identifies infection prevention, fluid management, and finding correctable technical complications as parts of that care. The review says retransplantation is the only treatment in severe cases.
Limits of Size Metrics
A study revisiting donor-recipient size mismatch in deceased-donor liver transplantation cautions that weight and body surface area (BSA) can be overestimated in patients with ascites. The authors say this raises questions about using the BSA index as a uniformly trustworthy surrogate for graft-size mismatch. Their point highlights a limitation of relying on that measure alone.
Weight-Ratio Comparison
A study of adult deceased-donor whole-liver transplantation compared outcomes across donor-recipient weight ratios (WR). It reports significantly decreased graft survival for small-for-size grafts with WR below 0.65 compared with the reference group (P = 0.01). The comparison reports graft survival figures of 90.2% at 1 year and 78.3% at 5 years.
What This Means for the Future of Liver Transplantation
The findings from this study highlight the need for increased awareness and consideration of liver size matching in deceased donor transplantation. While logistical challenges exist, strategies to optimize size compatibility could lead to improved patient and graft survival rates.
Reassessing Size Mismatch
A study titled “Revisiting the Prognostic Influences of Donor-Recipient Size Mismatch in Deceased Donor Liver Transplantation” says liver transplant outcomes are influenced by donor-recipient size mismatch. The study re-evaluated the impact of graft-size discrepancies on survival outcomes. Its stated focus is reassessment of that relationship in deceased-donor transplantation.
Directions for Future Research
An annual review of global liver transplantation research says future work may focus on integrating multidisciplinary approaches. It also identifies individualized treatment and emerging technologies as possible priorities. The review presents these as directions that may advance liver transplantation research globally.
An 82-Year-Old Recipient’s Recovery
A case report describes an 82-year-old man with chronic liver failure and polycystic liver disease who underwent in vivo split right triple lobe donor liver transplantation on October 29, 2021. The report says he made a remarkable recovery. He was discharged one month after surgery.
Future research should focus on developing more refined methods for assessing optimal liver size and predicting the impact of mismatches. This may involve advanced imaging techniques and computational models to better evaluate donor-recipient compatibility.
Ultimately, a more personalized approach to liver transplantation, incorporating careful size assessment and matching, has the potential to significantly enhance long-term outcomes for patients in need of this life-saving procedure.